BNP Paribas Financial Markets’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-117,451
| Closed | -$9.98M | – | 4568 |
|
|
2019
Q4 | $9.98M | Buy |
117,451
+104,065
| +777% | +$6.94M | 0.02% | 839 |
|
|
2019
Q3 | $669K | Buy |
13,386
+2,511
| +23% | +$100K | ﹤0.01% | 2047 |
|
|
2019
Q2 | $397K | Sell |
10,875
-7,259
| -40% | -$237K | ﹤0.01% | 2147 |
|
|
2019
Q1 | $507K | Buy |
18,134
+16,555
| +1,048% | +$390K | ﹤0.01% | 2096 |
|
|
2018
Q4 | $30.2K | Sell |
1,579
-2,287
| -59% | -$53.2K | ﹤0.01% | 2958 |
|
|
2018
Q3 | $116K | Buy |
3,866
+311
| +9% | +$11.7K | ﹤0.01% | 2665 |
|
|
2018
Q2 | $130K | Sell |
3,555
-18,468
| -84% | -$600K | ﹤0.01% | 2653 |
|
|
2018
Q1 | $725K | Sell |
22,023
-5,524
| -20% | -$173K | ﹤0.01% | 1952 |
|
|
2017
Q4 | $753K | Sell |
27,547
-6,782
| -20% | -$209K | ﹤0.01% | 2184 |
|
|
2017
Q3 | $1.27M | Buy |
34,329
+12,161
| +55% | +$448K | ﹤0.01% | 1403 |
|
|
2017
Q2 | $843K | Buy |
22,168
+7,554
| +52% | +$336K | ﹤0.01% | 1631 |
|
|
2017
Q1 | $715K | Buy |
14,614
+1,896
| +15% | +$86.5K | ﹤0.01% | 1537 |
|
|
2016
Q4 | $432K | Sell |
12,718
-2,558
| -17% | -$90.7K | ﹤0.01% | 1773 |
|
|
2016
Q3 | $577K | Sell |
15,276
-6,413
| -30% | -$242K | ﹤0.01% | 1152 |
|
|
2016
Q2 | $729K | Buy |
21,689
+11,522
| +113% | +$406K | ﹤0.01% | 1322 |
|
|
2016
Q1 | $323K | Sell |
10,167
-2,499
| -20% | -$81.6K | ﹤0.01% | 1336 |
|
|
2015
Q4 | $473K | Sell |
12,666
-894
| -7% | -$33.8K | ﹤0.01% | 1391 |
|
|
2015
Q3 | $515K | Buy |
13,560
+8,050
| +146% | +$283K | ﹤0.01% | 1350 |
|
|
2015
Q2 | $158K | Buy |
5,510
+3,972
| +258% | +$111K | ﹤0.01% | 1831 |
|
|
2015
Q1 | $43.1K | Buy |
+1,538
| New | +$43.2K | ﹤0.01% | 1990 |
|
|
2014
Q4 | – | Sell |
-3,935
| Closed | -$87.8K | – | 3579 |
|
|
2014
Q3 | $87.8K | Buy |
3,935
+3,798
| +2,772% | +$96.5K | ﹤0.01% | 2268 |
|
|
2014
Q2 | $3.98K | Buy |
137
+128
| +1,422% | +$3.42K | ﹤0.01% | 2710 |
|
|
2014
Q1 | $239 | Sell |
9
-812
| -99% | -$26.9K | ﹤0.01% | 3179 |
|
|
2013
Q4 | $31.7K | Sell |
821
-15,567
| -95% | -$557K | ﹤0.01% | 2057 |
|
|
2013
Q3 | $549K | Sell |
16,388
-5,110
| -24% | -$163K | ﹤0.01% | 1477 |
|
|
2013
Q2 | $661K | Buy |
+21,498
| New | +$719K | ﹤0.01% | 1299 |
|
Other funds holding MDCO
BNP Paribas Financial Markets's MDCO Position: Q1 2020 in Review
BNP Paribas Financial Markets sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 117,451 shares — an estimated $9.98M sold.
BNP Paribas Financial Markets first reported a position in MDCO in Q2 2013 and held it in 26 quarters. The position peaked at $9.98M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- BNP Paribas Financial Markets reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 117,451 Medicines Co shares in Q1 2020, an estimated $9.98M.
- BNP Paribas Financial Markets first reported a position in Medicines Co in Q2 2013 and held it in 26 quarters.
- BNP Paribas Financial Markets's Medicines Co position peaked at $9.98M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.